Xylavet injektionsvæske, opløsning 20 mg/ml
Xylavet injektionsvæske, opløsning 20 mg/ml
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
Xylavet injektionsvæske, opløsning 20 mg/ml
Xylavet 20 mg/ml injektionsvæske, opløsning
Active substance:
- Xylazine hydrochloride
Target species:
-
Horse
-
Dog
-
Cat
-
Cattle
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.31/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Horse
- Dog
- Cat
- Cattle
-
Intravenous use
- Horse
- Dog
- Cat
- Cattle
-
Subcutaneous use
- Dog
- Cat
- Cattle
- Horse
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Available in:
-
Denmark
Package description:
- Available only in Danish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biovet ApS
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 51537
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
How useful was this page?:
